Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Sunshine Biopharma (SBFM) over the last 11 years, with Q3 2025 value amounting to -$228322.0.

  • Sunshine Biopharma's Exchange Rate Effect fell 12956.46% to -$228322.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$538133.0, marking a year-over-year decrease of 69589.95%. This contributed to the annual value of -$1.0 million for FY2024, which is 29527.98% down from last year.
  • As of Q3 2025, Sunshine Biopharma's Exchange Rate Effect stood at -$228322.0, which was down 12956.46% from $335684.0 recorded in Q2 2025.
  • Sunshine Biopharma's Exchange Rate Effect's 5-year high stood at $772282.0 during Q3 2024, with a 5-year trough of -$636577.0 in Q2 2024.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$5664.0 (2021), whereas its average is -$13008.3.
  • In the last 5 years, Sunshine Biopharma's Exchange Rate Effect skyrocketed by 523070.27% in 2022 and then crashed by 2194431.5% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Exchange Rate Effect (Quarter) stood at -$5664.0 in 2021, then surged by 5230.7% to $290603.0 in 2022, then skyrocketed by 71.47% to $498306.0 in 2023, then tumbled by 227.49% to -$635298.0 in 2024, then soared by 64.06% to -$228322.0 in 2025.
  • Its Exchange Rate Effect was -$228322.0 in Q3 2025, compared to $335684.0 in Q2 2025 and -$10197.0 in Q1 2025.